FAKTOR-OPTIONSSCHEIN - DEXCOM Stock

DE000SU2U1C2

Market Closed - Börse Stuttgart 11:28:46 2024-06-21 am EDT
7.89 ^EUR	-5.51%

Current month	-10.14%
1 month	-35.22%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DEXCOM, INC.

Latest news about DEXCOM, INC.

Glucotrack Announces the Appointment of Andy Balo to Board of Directors	Jun. 20	CI
Dexcom Expands AID Partnership Into The Netherlands	Jun. 20	BU
Dexcom Expands Aid Partnership into the Netherlands	Jun. 20	CI
Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes	Jun. 20	BU

More news

Quotes 5-day view

Date	Price	Change
24-06-21	7.89	-5.51%
24-06-20	8.35	+6.23%
24-06-19	7.86	-5.42%
24-06-18	8.31	-1.54%
24-06-17	8.44	+3.43%

Delayed Quote Börse Stuttgart

Last update June 21, 2024 at 11:28 am EDT

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	DEXCOM, INC.
Issuer	Société Générale
WKN	SU2U1C
ISIN	DE000SU2U1C2
Date issued	2023-11-29
Strike	114 $
Maturity	Unlimited
Parity	1 : 1
Emission price	10.07 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	17.36 €
Lowest since issue	7.48 €
Spread	0.07 €
Spread %	0.83%

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

More about the company

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DexCom, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

116.6 USD

Average target price

150.3 USD

Spread / Average Target

+28.89%

Consensus